These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Facing facial weakness: psychosocial outcomes of facial weakness and reduced facial function in facioscapulohumeral muscular dystrophy. van de Geest-Buit WA; Rasing NB; Mul K; Deenen JCW; Vincenten SCC; Siemann I; Lanser A; Groothuis JT; van Engelen BG; Custers JAE; Voermans NC Disabil Rehabil; 2023 Jul; 45(15):2507-2516. PubMed ID: 35815498 [TBL] [Abstract][Full Text] [Related]
4. The facioscapulohumeral muscular dystrophy - health index: Italian validation of a disease-specific measure of symptomatic burden. Carraro E; Greco LC; Lizio A; Beretta M; Pozzi S; Casiraghi J; Becchiati S; Beshiri F; Frisoni MC; Iossa F; Heatwole C; Sansone V Disabil Rehabil; 2024 May; 46(10):2130-2137. PubMed ID: 37194629 [TBL] [Abstract][Full Text] [Related]
5. The Facioscapulohumeral Muscular Dystrophy-Health Index: Development and evaluation of a disease-specific outcome measure. Varma A; Weinstein J; Seabury J; Rosero S; Engebrecht C; Wagner E; Zizzi C; Luebbe EA; Dilek N; McDermott MP; Kissel J; Sansone V; Heatwole C Muscle Nerve; 2023 Oct; 68(4):422-431. PubMed ID: 37610084 [TBL] [Abstract][Full Text] [Related]
6. Treatment Approaches for Altered Facial Expression: A Systematic Review in Facioscapulohumeral Muscular Dystrophy and Other Neurological Diseases. Rasing NB; van de Geest-Buit WA; Chan OYA; Mul K; Lanser A; van Engelen BGM; Erasmus CE; Fischer AH; Ingels KJAO; Post B; Siemann I; Groothuis JT; Voermans NC J Neuromuscul Dis; 2024; 11(3):535-565. PubMed ID: 38517799 [TBL] [Abstract][Full Text] [Related]
7. Characterizing the face in facioscapulohumeral muscular dystrophy. Loonen TGJ; Horlings CGC; Vincenten SCC; Beurskens CHG; Knuijt S; Padberg GWAM; Statland JM; Voermans NC; Maal TJJ; van Engelen BGM; Mul K J Neurol; 2021 Apr; 268(4):1342-1350. PubMed ID: 33113021 [TBL] [Abstract][Full Text] [Related]
8. Experiences of patients with facioscapulohumeral dystrophy with facial weakness: a qualitative study. Sezer S; Cup EHC; Roets-Merken LM; Lanser A; Siemann I; Weikamp JG; Mul K; van Engelen BG; Satink T; Voermans NC Disabil Rehabil; 2022 Nov; 44(22):6775-6782. PubMed ID: 34529524 [TBL] [Abstract][Full Text] [Related]
9. Facioscapulohumeral muscular dystrophy Health Index: Japanese translation and validation study. Fujino H; Takahashi MP; Nakamura H; Heatwole CR; Takada H; Kuru S; Ogata K; Enomoto K; Hayashi Y; Imura O; Matsumura T Disabil Rehabil; 2024 Mar; ():1-10. PubMed ID: 38555736 [TBL] [Abstract][Full Text] [Related]
10. Rasch analysis to evaluate the motor function measure for patients with facioscapulohumeral muscular dystrophy. Mul K; Horlings CGC; Faber CG; van Engelen BGM; Merkies ISJ Int J Rehabil Res; 2021 Mar; 44(1):38-44. PubMed ID: 33165002 [TBL] [Abstract][Full Text] [Related]
12. A pediatric case report and literature review of facioscapulohumeral muscular dystrophy type1. Xiao T; Yang H; Gan S; Wu L Medicine (Baltimore); 2021 Nov; 100(47):e27907. PubMed ID: 34964760 [TBL] [Abstract][Full Text] [Related]